Breakthrough Research Offers Hope for Reversing Age-Related Egg Decline, Boosting IVF Success Rates
A potential game-changer in the field of assisted reproductive technology was unveiled this week, offering a glimmer of hope to women facing infertility due to declining egg quality. Scientists presented findings at the Fertility 2026 conference in Edinburgh suggesting they have successfully reversed a key age-related defect in human eggs, a development that could dramatically improve IVF success rates.
The emotional toll of IVF treatment is well-documented, a cycle of hope and despair familiar to countless individuals. This struggle is particularly acute for women over 35, where the likelihood of a successful pregnancy declines significantly. According to recent data from UK clinics, women under 35 experience an average birth rate of 35% per embryo transferred, a figure that plummets to just 5% for those aged 43-44. Crucially, experts emphasize that it is the age of the egg – not the woman – that is the primary determinant of success.
For decades, advancements in IVF, including genetic testing, egg freezing, and treatments for male infertility, have offered solutions to various challenges. However, the fundamental issue of age-related decline in egg quality has remained largely unaddressed. “Currently there are no methods for improving the ageing egg. It is a very large unmet need,” explained a leading scientist involved in the research. “This would be a first-in-class solution for improving egg quality.”
The groundbreaking research centers around a protein called Shugoshin 1. Scientists at the Max Planck Institute for Multidisciplinary Sciences in Göttingen, Germany, and co-founders of Ovo Labs, discovered that as eggs age, they produce less of this vital protein. Shugoshin 1 acts as a crucial “glue,” holding the egg’s chromosomes together in pairs. Without sufficient levels of this protein, chromosomes become unstable and prone to separation, leading to an increased risk of embryos with an incorrect number of chromosomes – a major cause of IVF failure.
“Female eggs sit there for a really long time,” noted a researcher at the University of Edinburgh. “It’s been quite hard to get a grip on what is going wrong with them. They’re meant to be dormant.” This dormancy, coupled with the lack of continuous replenishment seen in sperm production, makes eggs particularly vulnerable to the effects of aging.
The team’s experiments, presented in Edinburgh, demonstrated that supplementing eggs with Shugoshin 1 nearly halved the incidence of chromosomal defects. This suggests a potential therapeutic window during IVF, between egg retrieval and fertilization, where a rejuvenating microinjection could improve egg quality. “Our aim is to really reduce the time to successful conception,” stated a co-CEO of Ovo Labs. “Many more women would be able to conceive within a single IVF attempt.”
However, researchers caution that the work is still in its early stages. Years of further testing are required to confirm the safety and efficacy of the technique, and to determine if the observed improvements in egg quality translate into higher pregnancy rates. The field of IVF has, at times, been criticized for promoting expensive and unproven add-ons, and experts urge patients to remain cautiously optimistic.
“We don’t want to overpromise,” said a senior researcher. “We need to prove that this technique is safe and that it truly makes a difference.”
Despite the need for further investigation, the findings represent a significant step forward in addressing a major cause of female infertility. “While we await further details and confirmatory clinical trials, including addressing safety issues, these results have great potential for improving IVF success rates,” commented a leading expert in obstetrics and gynaecology at the University of Edinburgh, who was not involved in the study.
The emotional burden of IVF is immense, and the prospect of a more successful and less painful journey is a welcome one. “We all have friends who have been struggling with IVF,” said a researcher. “It’s a long journey and such an emotional burden. I really hope we can make this entire experience more successful.”
